From Liston Street Pulse:
Shares of Agenus Inc. (AGEN), a biotechnology company focused on the development and commercialization of technologies to treat cancers and infectious diseases, have surged in trading today after the company announced new Phase 3 data for GlaxoSmithKline's RTS.S malaria vaccine candidate. RTS.S contains Agenus' QS-21 Stimulon® 1adjuvant. The data was […]
The post Agenus Inc. Shares Rise Sharply appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015